In conclusion, our findings suggest that mortalin plays an important role in ovarian cancer development and progression by promoting tumour growth and migration/invasion in ovarian cancer, and mortalin is involved in the modulation of cell‐cycle–related proteins and the MAPK–ERK signalling pathway. Here, HSPA9 is linked to ovarian cancer.